Restless Legs Syndrome Treatment Market is driven by Increasing Patient Awareness
Restless Legs Syndrome (RLS) treatment encompasses therapeutic agents and supportive therapies aimed at alleviating uncomfortable sensations in the legs and improving sleep quality. The product portfolio includes dopaminergic agents such as ropinirole and pramipexole, alpha-2-delta ligands like gabapentin enacarbil, iron supplements, and opioid therapies, which collectively address the...
0 التعليقات 0 المشاركات 151 مشاهدة 0 معاينة